Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition
10.1371/journal.pone.0107772
Saved in:
Main Authors: | Sudo M., Yamaguchi Y., Späth P.J., Matsumoto-Morita K., Ong B.K., Shahrizaila N., Yuki N. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
Public Library of Science
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142484 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy
by: Yuki, N., et al.
Published: (2016) -
Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist's journey
by: Yuki, N.
Published: (2016) -
Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination
by: Yuki, N., et al.
Published: (2016) -
Intact NIST Monoclonal Antibody Characterization - Proteoforms, Glycoforms - using CE-MS and CE-LIF
by: Chien-Hsun Chen, et al.
Published: (2019) -
IVIG: are all brands the same?
by: อนันต์ชัย อัศวเมฆิน
Published: (2021)